Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Genprex, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −5 vs. Q4 2022
- Shares held
- 5.96M
- +1.93M (+47.8%) vs. Q4 2022
- Total value
- $5.42M
- −$412.5K (−7.1%) vs. Q4 2022
- New holders
- 6
- 12 more added
- Sold out
- 11
- 7 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $154.9K |
| Q1 2026 | 27 | $169.0K |
| Q4 2025 | 22 | $13.0K |
| Q3 2025 | 21 | $229.5K |
| Q2 2025 | 28 | $152.9K |
| Q1 2025 | 24 | $93.5K |
| Q4 2024 | 22 | $247.0K |
| Q3 2024 | 21 | $79.7K |
| Q2 2024 | 15 | $510.3K |
| Q1 2024 | 17 | $426.0K |
| Q4 2023 | 36 | $1.16M |
| Q3 2023 | 39 | $2.61M |
| Q2 2023 | 38 | $3.64M |
| Q1 2023 | 39 | $5.42M |
| Q4 2022 | 45 | $5.84M |
| Q3 2022 | 43 | $6.29M |
| Q2 2022 | 42 | $6.11M |
| Q1 2022 | 50 | $10.8M |
| Q4 2021 | 47 | $9.78M |
| Q3 2021 | 49 | $15.8M |
| Q2 2021 | 59 | $19.5M |
| Q1 2021 | 72 | $35.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Genprex, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,950,000 | $1.77M | 0.04% | +1,950,000 | New |
| Vanguard Group Inc | 1,826,600 | $1.66M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 568,240 | $517.0K | 0.00% | +3,612+0.6% | Added |
| Geode Capital Management, LLC | 447,211 | $406.9K | 0.00% | +15,074+3.5% | Added |
| State Street Corp | 172,439 | $156.9K | 0.00% | +42,700+32.9% | Added |
| Rockefeller Capital Management L.P. | 150,000 | $136.0K | 0.00% | +150,000 | New |
| Group One Trading, L.P. | 105,067 | $95.6K | 0.00% | +44,713+74.1% | Added |
| IHT Wealth Management, LLC | 82,372 | $75.0K | 0.00% | +29,997+57.3% | Added |
| Northern Trust Corp | 81,861 | $74.5K | 0.00% | −4,569−5.3% | Reduced |
| Two Sigma Securities, LLC | 77,219 | $70.3K | 0.01% | +77,219 | New |
| Silvercrest Asset Management Group LLC | 56,000 | $51.0K | 0.00% | 00.0% | Unchanged |
| Verus Capital Partners, LLC | 55,500 | $50.5K | 0.01% | −33,000−37.3% | Reduced |
| Renaissance Technologies LLC | 51,307 | $47.0K | 0.00% | −3,593−6.5% | Reduced |
| Staley Capital Advisers Inc | 50,000 | $45.0K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 37,476 | $34.1K | 0.00% | +2,326+6.6% | Added |
| Charles Schwab Investment Management Inc | 29,742 | $27.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 25,691 | $23.4K | 0.00% | +20,579+402.6% | Added |
| TCG Advisory Services, LLC | 22,000 | $20.0K | 0.00% | +1,000+4.8% | Added |
| Mariner, LLC | 20,000 | $18.0K | 0.00% | +20,000 | New |
| Bank of New York Mellon Corp | 17,569 | $16.0K | 0.00% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 17,000 | $15.5K | 0.00% | +17,000 | New |
| CCG Wealth Management, LLC | 15,100 | $13.7K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 13,608 | $12.4K | 0.00% | +698+5.4% | Added |
| Citadel Advisors LLC | 13,282 | $12.1K | 0.00% | −22,406−62.8% | Reduced |
| Price T Rowe Associates Inc | 12,600 | $12.0K | 0.00% | −13,000−50.8% | Reduced |
| Pekin Hardy Strauss, Inc. | 12,578 | $11.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,246 | $10.2K | 0.00% | −149,300−93.0% | Reduced |
| Tower Research Capital LLC (TRC) | 9,829 | $9.00K | 0.00% | +1,816+22.7% | Added |
| Advisor Group Holdings, Inc. | 9,262 | $8.42K | 0.00% | 00.0% | Unchanged |
| David Loasby | 10,000 | $8.30K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 5,000 | $4.55K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,705 | $3.00K | 0.00% | +1,205+48.2% | Added |
| VitalStone Financial, LLC | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 850 | $767 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 332 | $302 | 0.00% | +5+1.5% | Added |
| TCI Wealth Advisors, Inc. | 300 | $273 | 0.00% | 00.0% | Unchanged |
| Meeder Asset Management Inc | 271 | $247 | 0.00% | −8,903−97.0% | Reduced |
| Proequities, Inc. | 32 | $29 | 0.00% | +32 | New |
| JPMorgan Chase & Co | 177 | $0 | 0.00% | 00.0% | Unchanged |
| Cypress Capital, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −31,569−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −22,644−100.0% | Sold out |
| Per Stirling Capital Management, LLC. | 0 | $0 | 0.00% | −18,162−100.0% | Sold out |
| TCWP LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7,991−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Burleson & Company, LLC | – | – | – | – | Not filed |